XHALE, INC.

GAINESVILLE, FL · Founded 2005 · CIK 0001476509 · Medtech · Acquired

Breath-based adherence monitoring device (miniature gas chromatograph) that detects FDA-approved flavor markers in exhaled breath to confirm medication ingestion in real-time

Grants
$312K
1 award
Sector median: 1
Raised
$21M
2 Form D · Jul 2014
147 months since last filing
Contracts
—
No federal contracts on record
Patents
31
8 granted · 23 pending
Sector median: 2

Capital Timeline

Federal above the line · equity below · node area scaled to amount
Capital and federal award history
DateEventSourceAmount
Private capital raisedForm D · SEC$15,985,452
Private capital raisedForm D · SEC$4,552,730
Federal grantDepartment of Health and Human Services · Phase I · SMART: A Breath-based Adherence Technology to Monitor HIV Microbicide Gel Use$311,516
Federal grant · SBIR/STTRForm D · SEC

Peer position

Medtech · 4531 companies · ranked on federal contract value
Medtech companies ranked by federal contract value
#CompanyContractsDisclosed equity
902LS BIOPATH, INC.—$8.7M
903PEOPLE POWER COMPANY—$13M
904HEROWEAR, LLC—$965K
905XHALE, INC.—$21M
906CBLPath Holdings Corp—$3.2M
907Reach Neuro, Inc.—$200K
908PorOsteon, Inc.—$2.2M

Ranked on federal contract value rather than capital raised. The equity column is the comparison worth making — companies at the same procurement position often sit at very different points in their funding history.

Founders & Team

From Form D filings · 13 related persons
  • Richard AllenDirector · Executive Officer
  • Thomas BiggerExecutive Officer
  • David DizneyDirector
  • Dennis DonnExecutive Officer
  • Mark GoldDirector
  • John HarperDirector · Executive Officer
  • Paul HassieExecutive Officer
  • S. JohnsonDirector
  • Andrew KerseyExecutive Officer
  • Richard MelkerExecutive Officer
  • Nauman ToorDirector
  • Hank WohltjenDirector
  • Henry WohltjenDirector

Patents

USPTO · 8 granted of 31

Regulatory activity · Medtech

Sector-level, not company-level

Rules are matched to sector, not to company. Recent activity in a sector is context rather than a signal about this business — until rules are matched to what a company actually builds, the section is shown as context and nothing more.